News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Straumann Group reports strong growth in the second quarter and updates outlook due to selling DrSmile
Straumann Group reports strong growth in the second quarter, reaching CHF 1.3 billion in revenue with 16.1% organic growth. DrSmile to be sold to Impress Group while maintaining 20% holding. Updated outlook for 2024 shows double-digit revenue growth and profitability in the 27-28% range -